About Vipul Drugs Private Limited
Data last updated:
Vipul Drugs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 December 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U22330MH1991PTC064375. Its GSTIN is 27AAACV1977G1Z5 (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.73 Cr. It is led by directors Samir Navinchandra Mehta and Vipul Navinchandra Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 Anandi Villalajpatrai Road Vile Parle (W), Mumbai, Maharashtra, India – 400056.
As per MCA filings, the company has satisfied charges of ₹14.5 Cr on record. Court records list 44 cases involving the company, including 39 filed by the company and 5 filed against it; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vipuldrugs.com.
Company details
Contact details
Vipul Drugs Private Limited's registered office is in Mumbai, Maharashtra. Its website is vipuldrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address202 Anandi Villalajpatrai Road Vile Parle (W), Mumbai, Maharashtra, India – 400056
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vipul Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vipul Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Vipul Drugs Private Limited, buy the company report.
Financials of Vipul Drugs Private Limited
FY 2025 filings availableVipul Drugs Private Limited reported revenue of ₹3,130 (up 1336% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 85% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vipul Drugs Private Limited, buy the company report.
Board of directors of Vipul Drugs Private Limited
Vipul Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Navinchandra Mehta | Director | 18 Jun 1998 | 28 Years 4 Months | Current |
| Vipul Navinchandra Mehta | Director | 10 Dec 1991 | 34 Years 11 Months | Current |
Auditor
Vipul Drugs Private Limited is audited by VINIT KETKAR for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINIT KETKAR | FY 2023 | 047388 |
Shareholding
The shareholding of Vipul Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vipul Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Mar 2010 | 10211609 | Standard Chartered Bank | ₹5.5 Cr | Satisfied | |
| 21 Feb 2003 | 80010192 | The Greater Bombay Co-Op Bank Ltd | ₹1 Cr | Satisfied | |
| 12 Feb 2001 | 90165401 | The Grater Bank | ₹50 Lakh | Satisfied | |
| 12 Jan 2001 | 90165397 | The Grater Bank | ₹5 Cr | Satisfied | |
| 03 Mar 2000 | 90165360 | The Grater Bank | ₹2.5 Cr | Satisfied |
To see the full charge records of Vipul Drugs Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Vipul Drugs Private Limited has 44 court cases on record: 39 filed by Vipul Drugs, 5 filed against it. 4 cases are pending and 40 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 2 | 2 |
| High courts | 21 | 3 | 2 |
Cases on record (5 of 44)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against M/S Rajat Pharmachem Ltd and Ors and 2 others | Pending |
| High Court, MAHARASHTRA | Court case (ALP) | Filed by the company against M/S Sarvodaya Labs Ltd. and 4 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Summons For Judgement) | Filed by the company against Ms Unibios Laboratories Ltd | Disposed |
| Bombay High Court | Court case (CHOL) | Filed by the company against Rajat Pharmachem Ltd. | Disposed |
| Bombay High Court | Appeal | Filed by the company against M/S. Rajat Pharmachem Ltd. (in Liqun.) the Official Liquidator | Disposed |
To see the full case history of Vipul Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vipul Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vipul Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACV1977G1Z5 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vipul Drugs Private Limited, buy the company report.
Recent activity
Vipul Drugs Private Limited has 4 board changes on record since 1991: 3 appointments and 1 cessation. The latest: Navinchandra Mansukhlal Mehta ceased to be Director on 27 Nov 2015.
9 earlier events are in the company report.
Frequently asked questions
Vipul Drugs is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 December 1991 (35+ years old) and is registered under CIN U22330MH1991PTC064375.
Vipul Drugs has 2 current directors:
- Samir Navinchandra Mehta - Director
- Vipul Navinchandra Mehta - Director
The latest financial statements of Vipul Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vipul Drugs is 27AAACV1977G1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vipul Drugs is U22330MH1991PTC064375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vipul Drugs has 44 court cases on record: 39 filed by the company and 5 filed against it. 4 are pending. Most are in the district courts.
Vipul Drugs was incorporated on 10 December 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.
Navinchandra Mansukhlal Mehta ceased to be Director on 27 Nov 2015. Samir Navinchandra Mehta was appointed as Director on 18 Jun 1998. Navinchandra Mansukhlal Mehta was appointed as Director on 10 Dec 1991. Vipul Drugs has 4 board changes on record in total.
Vipul Drugs can be reached through the website vipuldrugs.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Vipul Drugs is at 202 Anandi Villalajpatrai Road Vile Parle W, Mumbai, Maharashtra, India – 400056.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
